what mimics glp-1 receptor agonists Understanding semaglutide (GLP-1 RA): Are

Some patients think they can use this drug for 1 year, it will fix their weight and eating problem, then they can stop it and maintain their lower body weight

Contrary to common knowledge, patients in the subgroup with a higher BMI did not show significant weight gain (WMD = 1.21 kg, 95% CI 1.24 to 3.60, P = 0.33, I 2 = 72%) and there were no significant differences between the subgroups ( P = 0.73) (Additional file 2: Fig

Liver Fibrosis, But No Other Histologic Features, Is Associated With Long-Term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

While GLP-1 medications offer several benefits, they also come with limitations and downsides that patients and healthcare providers need to consider

The safest way to switch doses : GLP-1s can have different starting doses and dosage schedules